Effect of lipoprotein (a) on annexin A5 binding to cell membrane

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 1915-1919

  Fu, Yi Chi ^a   Yang, Jen Tsung ^b   Chen, Hui Wen ^a   Wu, June Hsieh ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Annexin A5; Cell membrane; Enzyme linked immunosorbent assay; Flow cytometry; Lipoprotein (a); Phosphatidylserine

Indexed keywords

LIPOCORTIN 5; LIPOPROTEIN A; PHOSPHATIDYLSERINE;

ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CELL MEMBRANE; CELL STRAIN HEPG2; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; SUCROSE DENSITY GRADIENT CENTRIFUGATION; ULTRACENTRIFUGATION;

ANNEXIN A2; ANNEXIN A5; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HEP G2 CELLS; HUMANS; LIGANDS; LIPOPROTEIN(A); PHOSPHATIDYLSERINES; PROTEIN BINDING; STRESS, PHYSIOLOGICAL;

EID: 77957750114     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.07.036     Document Type: Article

References (33)

1. Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 1963, 59:369-382.
2. Brunner C., Kraft H.G., Utermann G., Muller H.J. Cys4057 of apolipoprotein (a) is essential for lipoprotein (a) assembly. Proc Natl Acad Sci U S A 1993, 90:11643-11647.
3. Reblin T., Meyer N., Labeur C., Henne-Bruns D., Beisiegel U. Extraction of lipoprotein (a), apoB, and apoE from fresh human arterial wall and atherosclerotic plaques. Atherosclerosis 1995, 113:179-188.
4. Wu J.H., Kao J.T., Wen M.S., Wu D. Coronary artery disease risk predicted by plasma concentrations of high-density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B, and lipoprotein (a) in a general Chinese population. Clin Chem 1993, 39:209-212.
5. Craig W.Y., Neveux L.M., Palomaki G.E., Cleaveland M.M., Haddow J.E. Lipoprotein (a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem 1998, 44:2301-2306.
6. McLean J.W., Tomlinson J.E., Kuang W.J., et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987, 330:132-137.
7. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmier G.G., Seitz G. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987, 80:458-465.
8. Romisch J., Schuler E., Bastian B., et al. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coag Fibrinol 1992, 3:11-17.
9. Morgan R.O., Bell D.W., Testa J.R., Fernandez M.P. Genomic locations of ANXII and ANX13 and the evolutionary genetics of human annexins. Genomics 1998, 48:100-110.
10. Song G., Campos B., Wagoner L.E., Dedman J.R., Walsh R.A. Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure. J Mol Cell Cardiol 1998, 30:443-451.
11. Reutelingsperger C.P., Hornstra G., Hemker H.C. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985, 151:625-629.
12. Kaetzel M.A., Hazarika P., Dedman J.R. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins. J Biol Chem 1989, 264:14463-14470.
13. Reutelingsperger C.P., van Heerde W.L. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 1997, 53:527-532.
14. Hajjar K.A., Jacovina A.T., Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994, 269:21191-21197.
15. Hajjar K.A., Gavish D., Breslow J.L., Nachman R.L. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989, 339:303-305.
16. Knight B.L., Perombelon Y.F., Soutar A.K., Wade D.P., Seed M. Catabolism of lipoprotein (a) in familial hypercholesterolaemic subjects. Atherosclerosis 1991, 87:227-237.
17. Frank S., Hrzenjek A., Blaschitz A., Dohr G., Kostner G.M. Role of various tissues in apo(a) fragmentation and excretion of fragments by the kidney. Eur J Clin Invest 2001, 31:504-512.
18. Jeffe E.A., Nachman R.L., Becker C.G., Minick R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
19. Srinivas K.S., Chandrasekar G., Srivastava R., Puvanakrishnan R. A novel protocol for subcellular fractionation of C3A hepatoma cells using sucrose density gradient centrifugation. J Biochem Biophys Methods 2004, 60:23-27.
20. Tilghman R.W., Hoover R.L. E-selectin and ICAM-1 are incorporated into detergent-insoluble membrane domains following clustering in endothelial cells. FEBS Lett 2002, 525:83-87.
21. Duk M., Lisowska E., Wu J.H., Wu A.M. The biotin/avidin-mediated microtiter plate lectin assay with the use of chemically modified glycoprotein ligand. Anal Biochem 1994, 221:266-272.
22. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
23. Hirt U.A., Leist M. Rapid noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 2003, 10:1156-1164.
24. Krahling S., Callahan M.K., Williamson P., Schlegel R.A. Exposure of phosphatidylserine is a general feature in phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ 1999, 6:183-189.
25. Bottcher A., Gaipl U.S., Fürnrohr B.G., et al. Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum 2006, 54:927-938.
26. Munoz L.E., Frey B., Pausch F., et al. The role of annexin A5 in the modulation of immune response against dying and dead cells. Curr Med Chem 2007, 14:271-277.
27. Sawabe M., Tanaka N., Nakahara K., et al. High lipoprotein (a) level promotes both coronary atherosclerosis and myocardial infarction: a path analysis using large number of autopsy cases. Heart 2009, 95:1997-2002.
28. Bergmark C., Dewan A., Orsoni A., et al. A novel function of lipoprotein as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res 2008, 49:2230-2239.
29. Hoover-Plow J., Hart E., Gong Y., Shchurin A., Schneeman T. A physiological function for apolipoprotein (a): a natural regulator of the inflammatory response. Exp Biol Med 2009, 243:28-34.
30. Sha J., McCullough B., Hart E., Nassir F., Davidson N.O., Hoover-Plow J. Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. J Thromb Haemostasis 2005, 3:2281-2289.
31. van Tits L.J., de Graaf J., Toenhake H., van Heerde W., Stalenhoef A. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 2005, 25:717-722.
32. Capila I., Hernaiz M.J., Mo Y.D., et al. Annexin V-heparin oligosaccharide complex suggests heparin sulfate-mediated assembly on cell surfaces. Structure 2001, 9:57-64.
33. Jamieson D.G., Usher D.C., Rader D.J., Lavi E. Apolipoprotein (a) deposition in atherosclerotic plaques of cerebral vessels, A potential role for endothelial cells in lesion formation. Am J Pathol 1995, 147:1567-1574.